O
OMIC

OrbiMed’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

OrbiMed’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,023
Closed -$152K – 140
2024
Q2 		$152K Hold
18,023
– – ﹤0.01% 114
2024
Q1 		$278K Hold
18,023
– – 0.01% 113
2023
Q4 		$249K Hold
18,023
– – 0.01% 110
2023
Q3 		$206K Hold
18,023
– – ﹤0.01% 127
2023
Q2 		$449K Hold
18,023
– – 0.01% 123
2023
Q1 		$654K Hold
18,023
– – 0.01% 119
2022
Q4 		$1.09M Hold
18,023
– – 0.02% 109
2022
Q3 		$1.35K Hold
18,023
– – 0.03% 124
2022
Q2 		$2.06K Sell
18,023
-58,670
-76% -$6.88M 0.04% 130
2022
Q1 		$14.5M Buy
76,693
+6,548
+9% +$1.52M 0.24% 81
2021
Q4 		$24.3M Buy
70,145
+3,528
+5% +$1.37M 0.31% 77
2021
Q3 		$22.4M Hold
66,617
– – 0.25% 91
2021
Q2 		$54.9M Buy
+66,617
New +$51.6M 0.56% 53

Other funds holding OMIC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return